Shanghai - Delayed Quote CNY

Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS)

Compare
36.90
+2.45
+(7.11%)
At close: 3:00:01 PM GMT+8
Loading Chart for 688131.SS
DELL
  • Previous Close 34.45
  • Open 34.47
  • Bid 36.88 x --
  • Ask 36.90 x --
  • Day's Range 34.47 - 37.27
  • 52 Week Range 17.94 - 48.39
  • Volume 2,581,050
  • Avg. Volume 3,294,136
  • Market Cap (intraday) 7.784B
  • Beta (5Y Monthly) 0.58
  • PE Ratio (TTM) 50.55
  • EPS (TTM) 0.73
  • Earnings Date --
  • Forward Dividend & Yield 0.08 (0.23%)
  • Ex-Dividend Date Oct 25, 2024
  • 1y Target Est --

Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

www.chemexpress.cn

3,370

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 688131.SS

View More

Performance Overview: 688131.SS

Trailing total returns as of 1/14/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

688131.SS
0.35%
SSE Composite Index
4.88%

1-Year Return

688131.SS
13.58%
SSE Composite Index
12.46%

3-Year Return

688131.SS
53.11%
SSE Composite Index
8.84%

5-Year Return

688131.SS
69.78%
SSE Composite Index
4.02%

Compare To: 688131.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 688131.SS

View More

Valuation Measures

As of 1/13/2025
  • Market Cap

    7.27B

  • Enterprise Value

    8.06B

  • Trailing P/E

    47.38

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.40

  • Price/Book (mrq)

    2.69

  • Enterprise Value/Revenue

    3.80

  • Enterprise Value/EBITDA

    43.79

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.19%

  • Return on Assets (ttm)

    2.67%

  • Return on Equity (ttm)

    5.78%

  • Revenue (ttm)

    2.12B

  • Net Income Avi to Common (ttm)

    152.63M

  • Diluted EPS (ttm)

    0.73

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    497.45M

  • Total Debt/Equity (mrq)

    49.09%

  • Levered Free Cash Flow (ttm)

    35.24M

Research Analysis: 688131.SS

View More

People Also Watch